Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 86, Issue 3, Pages 256-259Publisher
WILEY
DOI: 10.1111/j.1600-0609.2010.01561.x
Keywords
immune thrombocytopenic purpura; chronic immune thrombocytopenic purpura; rituximab
Categories
Ask authors/readers for more resources
The management of patients with refractory immune thrombocytopenic purpura (ITP) may be difficult. We describe a rapid-onset very long-term remission (9 years) induced by short-term rituximab monotherapy in a 62-year-old man with treatment-refractory chronic ITP. Over a 30-year period from the original diagnosis to last follow-up, the patient needed renewed treatment twelve times within the first two decades and was subsequently brought in continuous complete remission for the last decade by a single course of rituximab. The effect of rituximab in ITP has previously been described. However, in chronic, treatment-refractory ITP occurring in elderly patients, remission rates tend to be low and of short duration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available